TWiV 1246: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin with Vincent
Racaniello discusses outbreaks of Vibrio vulnificus and
Legionnaire’s disease in Harlem, the role of the American
Association of Pediatrics defining immunization practices, before
Dr. Griffin deep dives into recent statistics on RSV, influenza
and SARS-CoV-2 infections, the Wasterwater Scan dashboard,
effective of the high and low does influenza vaccines,
association Gullian-Barre syndrome with RSV vaccination,
guidelines for using RSV vaccines, whether or not the NB.1.8.1
should be included in the fall 2025 vaccines, where to find
PEMGARDA, long COVID treatment center, where to go for answers to
your long COVID questions, vascular aging after COVID-19 and
contacting your federal government representative to stop the
assault on science and biomedical research.


Subscribe (free): Apple
Podcasts, RSS, email


Become a patron of TWiV!
Links for this episode

Department of Public Health alerts public to
rare Vibrio vulnificus bacteria in
coastal waters (Mass.gov)


Legionnaires’ Disease: In Harlem (NYC Health)

Ivermectin to Control
Malaria (NEJM)

AAP has been leading voice on
childhood vaccine recommendations since 1930s

(American Academy of Pediatrics)

The American Academy of Pediatrics Releases Its
Own Evidence-Based Immunization
Schedule (American Academy of
Pediatrics)


Wastewater for measles (WasterWater Scan)

Measles cases and outbreaks (CDC
Rubeola)


Weekly measles and rubella monitoring
(Government of Canada)

Health Ministry says unvaccinated 18-month-old
dies of measles (Times of Israel)


Ten countries in the Americas report
measles outbreaks in 2025 (PAHO: Pan American Health
Organization)


Measles (WHO)

Get the FACTS about measles (NY
State Department of Health)

Measles vaccine recommendations from NYP
(jpg)


Measles (CDC Measles (Rubeola))


Measles vaccine (CDC Measles (Rubeola))


Presumptive evidence of measles immunity
(CDC)


Contraindications and precautions to
measles vaccination (CDC)


Measles (CDC Measles (Rubeola))

Adverse events associated with childhood
vaccines: evidence bearing on causality (NLM)

Measles Vaccination: Know the
Facts (ISDA: Infectious Diseases Society of America)

Deaths following vaccination: what does
the evidence show (Vaccine)

Influenza: Waste water scan for 11
pathogens (WastewaterSCan)

US respiratory virus activity (CDC
Respiratory Illnesses)

Respiratory virus activity levels
(CDC Respiratory Illnesses)

Weekly surveillance report: clift
notes (CDC FluView)

Relative effectiveness of high-dose versus
standard-dose influenza vaccine against
hospitalizations and mortality according to frailty score (JID)


FDA-CDC-DOD: 2025-2046 influenza vaccine
composition (FDA)

RSV: Waste water scan for 11
pathogens (WastewaterSCan)

US respiratory virus activity (CDC
Respiratory Illnesses)

ENFLONSIA: novel
drug approvals 2025 (FDA)

RSV-Network (CDC Respiratory Syncytial virus
Infection)


Vaccines for Adults (CDC: Respiratory
Syncytial Virus Infection (RSV))

Evaluation of Guillain-Barré Syndrome
(GBS) following Respiratory Syncytial Virus (RSV)
Vaccination Among Adults 65 Years and Older (FDA)


Economic Analysis of Protein Subunit and
mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP)

Evidence
to Recommendations Framework
(EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National
Center for Immunization and Respiratory Diseases)

Waste water scan for 11
pathogens (WastewaterSCan)

COVID-19 deaths (CDC)

Respiratory Illnesses Data
Channel (CDC: Respiratory Illnesses)

COVID-19 national and
regional trends (CDC)

COVID-19 variant tracker (CDC)

SARS-CoV-2 genomes galore
(Nextstrain)

Antigenic and Virological Characteristics of SARS-CoV-2
Variant BA.3.2, XFG, and
NB.1.8.1 (biRxiV)


Where to get pemgarda (Pemgarda)


EUA for the pre-exposure
prophylaxis of COVID-19 (INVIYD)

Infusion center (Prime Fusions)


CDC Quarantine guidelines (CDC)


NIH COVID-19 treatment guidelines (NIH)

Drug
interaction checker (University of
Liverpool)


Paxlovid (Pfizer)


Infectious Disease Society guidelines for
treatment and management (ID Society)

Molnupiravir safety and efficacy
(JMV)

Convalescent plasma recommendation
for immunocompromised (ID Society)

What to do when sick with a respiratory
virus (CDC)

Managing healthcare
staffing shortages (CDC)

Steroids,dexamethasone at the right
time (OFID)


Anticoagulation guidelines
(hematology.org)

Daniel Griffin’s evidence
based medical practices for long COVID (OFID)

Long COVID hotline (Columbia :
Columbia University Irving Medical Center)


The answers: Long COVID

Accelerated vascular ageing after
COVID-19 infection: the CARTESIAN study (European Heart Journal)

Reaching out to US house representative


Letters read on TWiV 1246

Dr. Griffin’s COVID treatment summary (pdf)

Timestamps by Jolene Ramsey. Thanks!



Intro music is by Ronald Jenkees


Send your questions for Dr. Griffin to daniel@microbe.tv


Content in this podcast should not be construed as medical
advice.